Scientific Terms
Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug
The companies will jointly develop and commercialize Guardant360 CDx and Guardant360 TissueNext for taletrectinib treatment in advanced and metastatic NSCLC.
The firm plans to present data from a large validation study of the Signal-C early detection test later this year as it contemplates approval.
FIND, Indonesia Partner on Diagnostic Testing Access Initiative
FIND will work with the Ministry of Health of the Republic of Indonesia to improve access to diagnostics and digital health technologies in the Asian country.
Dxcover Raises $11.9M to Bring Infrared Spectroscopy Cancer Detection Assay to Market
The firm is advancing what it describes as an infrared spectroscopy-based platform for early cancer detection, with initial data in brain tumors.
Guardant Health to Integrate Lunit's AI PD-L1 Scoring Algorithm Into Tissue Test Offering
The companies have been working together since 2021 following a strategic investment by Guardant in the South Korean AI firm.